Answers are grounded in this paper and cite their sources.
An elevated haemoglobin A2 percentage has been reported in HIV-infected patients, possibly attributable to therapy. In cross-sectional and cohort studies we have established that A2 is often elevated in untreated patients; a further rise during treatment is attributable specifically to zidovudine. The haemoglobin A2 may be high enough to lead to a misdiagnosis of beta thalassemia trait if there is a lack of awareness of this unexpected effect of HIV infection and its treatment.
No takes yet. Share an insight, caveat, or question.
Wilkinson et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: